CN118256459A - Recombinase and application thereof in degradation of aflatoxin B1Application in (a) - Google Patents
Recombinase and application thereof in degradation of aflatoxin B1Application in (a) Download PDFInfo
- Publication number
- CN118256459A CN118256459A CN202410395383.0A CN202410395383A CN118256459A CN 118256459 A CN118256459 A CN 118256459A CN 202410395383 A CN202410395383 A CN 202410395383A CN 118256459 A CN118256459 A CN 118256459A
- Authority
- CN
- China
- Prior art keywords
- recombinase
- afb
- enzyme
- recombinant
- aflatoxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000018120 Recombinases Human genes 0.000 title claims abstract description 38
- 108010091086 Recombinases Proteins 0.000 title claims abstract description 38
- 238000006731 degradation reaction Methods 0.000 title description 30
- 230000015556 catabolic process Effects 0.000 title description 29
- 229930195730 Aflatoxin Natural products 0.000 title 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 title 1
- 239000005409 aflatoxin Substances 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 37
- 108090000790 Enzymes Proteins 0.000 claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- 230000000593 degrading effect Effects 0.000 claims abstract description 26
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 16
- 239000013604 expression vector Substances 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 17
- 241000588724 Escherichia coli Species 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000006911 enzymatic reaction Methods 0.000 claims description 5
- 238000001976 enzyme digestion Methods 0.000 claims description 4
- 239000013598 vector Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 abstract description 32
- 108700020788 multicopper oxidase Proteins 0.000 abstract description 32
- 102000043368 Multicopper oxidase Human genes 0.000 abstract description 31
- 239000000835 fiber Substances 0.000 abstract description 7
- 230000002255 enzymatic effect Effects 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 3
- 229940079919 digestives enzyme preparation Drugs 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 2
- 230000009465 prokaryotic expression Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 10
- 238000001784 detoxification Methods 0.000 description 9
- 210000003722 extracellular fluid Anatomy 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 229910021645 metal ion Inorganic materials 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 6
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 108010029541 Laccase Proteins 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 108010037176 copper oxidase Proteins 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000012148 binding buffer Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 108010015428 Bilirubin oxidase Proteins 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- 238000003766 bioinformatics method Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000186221 Cellulosimicrobium cellulans Species 0.000 description 1
- 241000079938 Cellulosimicrobium funkei Species 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 102100029104 Ferroxidase HEPHL1 Human genes 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 108010025915 Nitrite Reductases Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 239000000589 Siderophore Substances 0.000 description 1
- 241000122971 Stenotrophomonas Species 0.000 description 1
- 241000610448 Stenotrophomonas acidaminiphila Species 0.000 description 1
- 241001537924 Tetracoccus <angiosperm> Species 0.000 description 1
- 241000500332 Tetragenococcus halophilus Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 239000002115 aflatoxin B1 Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- -1 ascorbate ions Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003385 ring cleavage reaction Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Abstract
The invention discloses a recombinase, the amino acid sequence of which is shown as SEQ ID NO. 1, the nucleotide sequence of a coding gene is shown as SEQ ID NO. 2, and the recombinase belongs to a multi-copper oxidase superfamily. The expression vector is constructed and prokaryotic expression is carried out to obtain the recombinase, and the enzymatic characteristics of the recombinase are researched, so that the recombinase can be found to degrade AFB 1 efficiently. The invention enriches the types of AFB 1 degrading enzymes, provides better choice for solving the pollution of agricultural products and feeds, and simultaneously provides theoretical basis for clarifying the action mechanism of the Fenton fiber microzyme and reasonably applying microorganism and enzyme preparations.
Description
Technical Field
The invention relates to a recombinase for degrading aflatoxin B 1 and application thereof, belonging to the field of biology.
Background
Aflatoxin B 1(Aflatoxin B1,AFB1) is the most widely polluted and extremely toxic mycotoxin in foods and feeds, and can cause economic loss and seriously harm the health of people and animals. Animals ingest AFB 1 -contaminated feed, resulting in the remaining of its metabolites in eggs, milk products and meats, which are harmful to human health. AFB 1 has hepatotoxicity, immunotoxicity, genotoxicity, mutagenicity, etc., and liver and kidney are main target organs, and long-term low-level contact with AFB 1 can cause chronic toxicity and even liver cancer.
Currently, the detoxification methods of AFB 1 mainly include a physical detoxification method, a chemical detoxification method and a biological detoxification method. The physical removal of AFB 1 mainly comprises adsorption, heating, ultraviolet irradiation, solvent extraction, and the like. The chemical detoxication method mainly uses chemical additives to destroy the toxic structure of AFB 1, so that the AFB 1 is decomposed into low-toxicity or nontoxic compounds, and is mainly divided into an alkali treatment method and an oxidation treatment method. The physicochemical detoxification method has the defects of poor detoxification effect, influence on the taste of the feed, reduction of the nutritional value of the feed and the like. The biological detoxification method has mild action conditions, good specificity, high detoxification efficiency, no pollution to the environment and capability of destroying the chemical structure of the AFB 1, and has become the main trend of the detoxification research of the AFB 1.
The microbial degradation of AFB 1 has short time and low cost, and does not affect the nutrition quality of the feed, so the microbial degradation is the first choice in the feed industry. AFB 1 degrading bacteria such as Cellulomyces tenuis (Cellulosimicrobium funkei), tetracoccus halophilus (Tetragenococcus halophilus), stenotrophomonas (Stenotrophomonas acidaminiphila) and Bacillus licheniformis (Bacillus licheniformis) can effectively degrade AFB 1, but the strains separated from the nature can be pathogenic bacteria or conditional pathogenic bacteria, and the living bacteria preparation is directly used as a feed additive or a food additive, which may cause biosafety problem or refusal of eating by animals, and is not suitable for practical production. The enzyme secreted by the microorganism in the growth process is utilized to change the structure of AFB 1 for degradation, and the possible ways of degrading AFB 1 mainly involve ring cleavage, hydrolysis, decarboxylation or deamination, so that compared with the microorganism, the enzyme is convenient to use and has been widely accepted in the food and feed industries.
The multiple copper oxidase superfamily can oxidize a variety of substrates, such as lignin-rich aromatic compounds, polyphenols, metal ions, ascorbate ions, siderophores, pigments, and the like, using molecular oxygen as an electron acceptor. All the amino acid sequences of the multicopper oxidases comprise a 10kDa-20kDa copper-reducing protein-like domain, and the multicopper oxidases can be divided into enzymes comprising 2 domains, 3 domains and 6 domains, depending on the number of copper-reducing protein-like domains, which include laccase (EC 1.10.3.2), ascorbate oxidase (EC 1.10.3.3), nitrite reductase (EC 1.7.2.1), bilirubin oxidase (EC 1.3.3.5), and metallooxidase (EC 1.16.3.1), etc. Laccase has been reported to have a good effect of degrading AFB 1, and is widely used in related enzyme preparations. However, there is still a lack of AFB 1 degrading enzymes suitable for industrial production.
In summary, to solve the problem of pollution of AFB 1 in agricultural products, feed materials and feeds, it is necessary to screen more enzymes capable of safely and effectively degrading AFB 1, so as to enrich the variety of AFB 1 degrading enzymes, provide theoretical basis for enzyme preparation utilized in actual production, and reduce economic loss of the aquaculture industry.
Disclosure of Invention
The first object of the present invention is a novel aflatoxin B 1 degrading enzyme.
The Fennella has very high degradation activity of aflatoxin B 1, and the applicant screens an enzyme capable of efficiently degrading aflatoxin B 1 from the Fennella by a molecular biological means, and the enzyme belongs to a multi-copper oxidase superfamily. Further, the applicant optimizes the sequence of the multi-copper oxidase and constructs an expression vector, and prokaryotic expression is carried out to obtain the recombinase, so that the activity of the recombinase in degrading aflatoxin B 1 is verified.
The amino acid sequence of the recombinase is shown as SEQ ID NO. 1.
The nucleotide sequence of the gene for encoding the recombinase is shown as SEQ ID NO.2.
The invention further provides a method for preparing the recombinase, which comprises the following steps:
(1) The gene sequence of the recombinant enzyme is connected with a vector plasmid in an enzyme digestion way, so as to obtain an expression vector containing a target gene;
(2) Transforming competent cells by using the obtained expression vector to obtain recombinant bacteria for expressing the target protein;
(3) And separating and purifying the recombinant enzyme from the recombinant bacteria.
The invention also provides application of the recombinase, or the coding gene thereof, or the expression vector thereof or the recombinant bacterium in degradation of aflatoxin B 1.
The invention further provides a method for degrading aflatoxin B 1, which comprises the following steps: the recombinant enzyme is added into a polluted sample of aflatoxin B 1 for enzymatic reaction.
Preferably, the temperature of the enzymatic reaction is 30 ℃ to 50 ℃ and the pH is neutral or slightly alkaline.
The invention also provides an enzyme preparation for degrading aflatoxin B 1, which contains the recombinase.
The beneficial effects of the invention are as follows:
The invention separates, identifies and re-obtains a new AFB 1 degrading enzyme from the Fennella, enriches the variety of the AFB 1 degrading enzyme, provides better choice for solving the pollution of agricultural products and feeds, and simultaneously is beneficial to elucidating the action mechanism of the Fennella and provides theoretical basis for the application of microorganisms and enzyme preparations.
Drawings
Fig. 1: molecular docking results of AFB 1 and the Fenton fiber microzyme multi-copper oxidase, and a left graph is a 3D graph after the multi-copper oxidase is docked with AFB 1; the right panel shows 2D interactive images of the docking of AFB 1 ligand with multiple copper oxidases.
Fig. 2: the MW is the molecular weight of the protein Marker as a result of the expression test of the recombinant multi-copper oxidase; Is an uninduced strain; NPE is the supernatant protein; DPE is inclusion body protein; the No.1 strain is escherichia coli BL21 (DE 3); no.2 strain is E.coli T7E.
Fig. 3: SDS-PAGE detection result of recombinant multicopper oxidase.
Fig. 4: effect of enzyme concentration of different recombinant multicopper oxidase on degradation effects of AFB 1.
Fig. 5: effect of different reaction pH on the effect of recombinant multicopper oxidase on degradation of AFB 1.
Fig. 6: effect of different reaction temperatures on the effect of recombinant multicopper oxidase on the degradation of AFB 1.
Fig. 7: the linear equation of dynamics of the recombinant multicopper oxidase degradation AFB 1.
Fig. 8: influence of metal ions on the effect of recombinant multicopper oxidase on the degradation of AFB 1.
Detailed Description
The technical scheme of the invention is further described in detail below with reference to specific embodiments. It should be understood that the following examples are illustrative of the present invention and are not intended to limit the scope of the present invention. Various modifications and equivalent substitutions will occur to those skilled in the art based on the following examples, and are also considered to be within the scope of the present invention. The experimental procedures, which are not specified in the following examples, are generally carried out according to conventional conditions or instructions or according to the procedures suggested in the operating manual provided by the manufacturer.
Key materials and description:
Fender fiber microzyme: the Fennella SLAQ strain is purchased from China Center for Type Culture Collection (CCTCC) No. M2013564, and is disclosed in patent document CN 103725636A.
PET-28b-3C vector plasmid: purchased from beijing bang allied biogenic technologies limited.
Coli BL21 (DE 3) strain: the E.coli expression strain is most commonly available from Shanghai ze Biotechnology Inc.
Coli T7E strain: purchased from Beijing village allied biogenic gene technology Co., ltd, is an E.coli BL21 enhanced strain.
Example 1 screening test for aflatoxin B 1 degrading enzyme in Cellularomyces fens
(1) Culturing the Fender fiber microzyme in LB broth to prepare extracellular fluid and intracellular fluid respectively, then taking each component to react with AFB 1 (10 mug/mL), extracting AFB 1 after the reaction is finished, and measuring the degradation rate of AFB 1. The results showed that the degradation rate of extracellular fluid to AFB 1 was 82.07% and the degradation rate of intracellular fluid to AFB 1 was 6.19%, indicating that the component degrading AFB 1 in the Cellularomyces fimbriae was mainly extracellular.
(2) After the extracellular fluid is added with proteinase K or is subjected to heat denaturation treatment, the efficiency of degrading AFB 1 by the extracellular fluid is obviously reduced, and the ingredient which plays the role of degrading AFB 1 in the extracellular fluid is presumed to be protein. And then sequentially carrying out gradient centrifugation, separation and concentration on extracellular fluid by using a 30kDa, 10kDa and 3kDa ultrafiltration tube, and carrying out co-culture on each component obtained by concentration and AFB 1 again and measuring the degradation rate, wherein the effect of degrading AFB 1 by the component with the molecular weight of 10kDa-30kDa is found to be significantly higher than that of other components. Continuing to examine the degradation activity of the component with the molecular weight of 10kDa-30kDa on AFB 1 under the conditions of different time, temperature, pH and metal ion addition, the component is found to accord with the enzymatic characteristics, and extracellular fluid is presumed to degrade AFB 1 through enzymatic reaction.
(3) Extracting DNA of the Fennella, carrying out library construction and bioinformatics analysis on the DNA, and obtaining annotation results of the Fennella genes according to the sequencing results.
(4) And (3) performing SDS-PAGE electrophoresis detection on the 10kDa-30kDa extracellular fluid component obtained by separation and purification in the step (2), identifying active proteins, and predicting the physicochemical properties such as hydrophobicity, molecular formula, isoelectric point, stability and the like of the obtained protein amino acid sequence through an online website (https:// web. Expasy org/protparam /). 81 proteins were detected in total, and the 81 proteins were classified according to their enzymatic reactivity to give 56 enzymes belonging to the major classes of oxidoreductase, transferase, isomerase, synthetase and hydrolase 5, respectively, with the most proteins belonging to the classes of oxidoreductase and hydrolase. According to the literature referred in the prior art, the oxidoreductase is closely related to the degradation of AFB 1, and the molecular docking result shows that a multi-copper oxidase is probably a key enzyme for degrading AFB 1 in 13 proteins of the oxidoreductase class, and the enzyme codes 970 amino acids, and the protein has a molecular weight of 98.46kDa and better stability.
TABLE 1 class of oxidoreductase and physicochemical Properties of the extracellular fluid fraction of the 10kDa-30kDa of Cellularomyces fens
Note that: * Representing the predicted physicochemical properties of the online website. A instability factor greater than 40 indicates that the protein is unstable.
(5) The secondary structure of AFB 1 was obtained by PubChem (https:// pubchem. Ncbi. Lm. Nih. Gov /), the multicopper oxidase homology was modeled using the protein modeling platform of the subject group, and the binding site between the target protein and AFB 1 was modeled using MOE software (version number 2019.0102). As can be seen from FIG. 1, there is a hydrogen bond force between AFB 1 and Arg794 of the multicopper oxidase, the hydrogen bond length isArene hydrogen bond acting force exists between Trp798 and the hydrogen bond is as long asIt was demonstrated that these two amino acid residues are likely the key amino acids for binding of the multicopper oxidase to AFB 1. In addition, AFB 1 has an S value of-7.40 and an RMSD value of 0.80 for the butt joint with the multicopper oxidase. Therefore, the AFB 1 and the multicopper oxidase have better butt joint binding force.
(6) In order to evaluate the homology of the amino acid sequence of the Fenton fiber microzyme, the amino acid sequence of the Fenton fiber microzyme is compared with the amino acid sequence of laccase reported in a literature and directly compared in NCBI database, and the test has low homology of the amino acid sequence of the multi-copper oxidase and the laccase. In addition, the amino acid sequences of 100 proteins from different strains containing the domains of the multicopper oxidase were aligned, wherein the amino acid sequence homology of the multicopper oxidase of this test with the protein (Cellulosimicrobium cellulans) containing the domains of the multicopper oxidase was highest, up to 99.90%.
TABLE 2 alignment of amino acid sequence homology of Fender fiber microzyme multicopper oxidase
Note that: only the first ten with a high degree of amino acid sequence homology match are shown.
Example 2 sequence optimization and recombinant expression of a multicopper oxidase
1. Amino acid sequence optimization of multiple copper oxidases
The resulting multicopper oxidase amino acid sequences from this experiment were predicted via an online website for signal peptide cleavage sites (https:// services. Healthcare. Dtu. Dk/services. PhpSignal P-5.0), glycosylation sites (https:// services. Healthcare. Dtu. Dgy-1.0) and transmembrane domains (https:// services. Healthcare. Dk/services/TMHMM-2.0 /). Considering both bioinformatics analysis and information on homologous proteins (accession number: UTT 60473.1), we cut Val547-Pro970 as the target amino acid sequence and carried the His tag on the N-terminus for better expression of the multicopper oxidase in E.coli supernatant.
2. Primer design, enzyme digestion and connection carrier of recombinant multi-copper oxidase genes
(1) According to the plasmid map of the Escherichia coli pET-28b-3C, a primer and a restriction enzyme site are designed, wherein the two ends of the primer comprise BamHI restriction enzyme sites (5 '-GGATCC-3')/HindIII restriction enzyme sites (5 '-AAGCTT-3'), and the primer is designed as follows:
The six bases underlined in the following :5'-GGATCCatgggcagcagccatcatcatcatcatcatagcagcggcctggaagttctgttccaggggcccggatccGTGGCAACAGGTCGTACC-3'( of the upstream primer represent BamHI cleavage sites and the lower case base represents His tag
The downstream primers were as follows: (underlined three bases represent stop codons, italics six bases represent HindIII cleavage sites)
(2) Synthesizing target genes of the multi-copper oxidase by a DNA synthesizer;
(3) 2% agarose gel electrophoresis and fragment gel recovery:
A, preparing 2% agarose gel (1 g agarose is added into 50mL TAE), slightly mixing, and heating in a microwave oven for 2min-2.5min until the mixture is clear and transparent;
B, standing for 1-3 min, and adding 5 mu L Goldview nucleic acid dye after the solution is slightly cooled, and uniformly mixing;
C, slowly pouring the solution into a gel preparation tank, inserting a gel comb, standing for 15-20 min, putting the gel into an electrophoresis tank after the agarose gel is completely solidified, and adding electrophoresis liquid until the gel is completely immersed;
D, spot-adding DNA sample mixed with 5X reducibility Loading buffer and DNA MARKER, voltage 140V, electrophoresis for 20min;
E, rapidly cutting off a strip of the multi-copper oxidase under an ultraviolet analyzer to prevent mutation caused by ultraviolet;
f, placing the cut agarose gel with the target band into a 1.5mL centrifuge tube without enzyme and weighing;
G, adding an equal amount of Binding Buffer (XPZ) according to 1G/mL; water bath at 55-60 ℃ until the gel is completely melted; transferring the melted solution into HiBind DNA Column, and sleeving HiBind DNA Column on a waste liquid collecting pipe; centrifuging at room temperature at maximum rotation speed (13000 r/min) for 1min, and discarding the waste liquid;
h, adding 300 mu L of Binding Buffer (XPZ), centrifuging at the maximum rotation speed at room temperature for 1min (13000 r/min), and discarding the waste liquid;
I, adding 700 mu L SPW Wash Buffer to elute Binding Buffer, centrifuging at the maximum rotation speed of room temperature (13000 r/min) for 2min, and discarding waste liquid; repeating the elution twice; centrifuging at room temperature at maximum rotation speed (13000 r/min) for 2min, and drying HiBind DNA Column;
J, sleeving HiBind DNA Column on a new enzyme-free 1.5mL centrifuge tube, adding 15 mu L of DEPC water, standing for 1min to dissolve DNA, and centrifuging at a maximum rotation speed of (13000 r/min) for 1min at room temperature; repeating the elution twice; the purified DNA solution was stored in a refrigerator at-20 ℃.
(4) The target gene fragment is cloned into a pET-28b-3C vector by BamHI/HindIII, and the specific steps are as follows:
A, constructing an enzyme digestion system, as shown in the following table:
Additive amount | |
Upstream: bamHI enzyme | 1μL |
Downstream: hindIII enzyme | 1μL |
10×buffer | 25μL |
Recovery of product DNA from gel | 2μg |
DEPC water | Make up to 50 mu L |
And B, placing the reaction system in a PCR instrument to react for 15min at 37 ℃.
C, the connection system is as follows:
and D, placing the reaction system in a PCR instrument to react for 15min at 37 ℃.
3. Plasmid transformed expression strains
(1) Adding proper amount of plasmid (1-2 μL) into competent cells (E.coli BL21 (DE 3) strain No.1 and E.coli T7E strain No. 2) prepared in advance;
(2) Placing on ice for 30min, and performing heat shock in a water bath at 42 ℃ for 90s;
(3) Adding a proper amount of antibiotic-free LB liquid medium, and incubating for 40min at 37 ℃ and 150 r/min;
(4) The mixture was inoculated with a loop to LB solid plates with the corresponding resistance and incubated overnight in a 37℃incubator.
4. Expression test of recombinant enzyme
(1) Selecting a monoclonal from the culture dish to 3mL of corresponding resistant LB culture medium, and culturing for 3-4 h at 37 ℃ and 200 r/min;
(2) Taking 1.5mL of bacterial liquid to a new 15mL centrifuge tube, adding 1.5 mu L of Isopropyl thiogalactoside (Isopropyl-beta-D-thiogalactoside, IPTG) with a final concentration of 1mmol/L, and performing induction culture at 37 ℃ and 200r/min for 4h; 1.5 mu L of IPTG is added into the residual 1.5mL of bacterial liquid, the temperature is 16 ℃, and the induction culture is carried out at 200r/min for overnight;
(3) Collecting the bacterial liquid after the induction into a 1.5mL centrifuge tube, centrifuging at 10000r/min for 1min, and discarding the supernatant; 1mL of 1 XPBS was added to the pellet to sonicate the cells;
(4) Centrifuging at 10000r/min for 1min, collecting 100 μl of supernatant labeled "NPE", discarding redundant supernatant, adding 100 μl of 1 XPBS (containing 8mmol/L urea) into the precipitate, and re-suspending to obtain "DPE";
(5) To the sample, 25. Mu.L of 5 Xreducing Loading buffer was added, and after boiling for 10 minutes, SDS-PAGE was performed.
The recombinant enzyme is expressed in both supernatant (NPE) and inclusion bodies (DPE), and the optimal expression condition is that the Escherichia coli strain No.2 (Escherichia coli T7E strain) is cultured for 4 hours at 37 ℃, and the supernatant is centrifugally taken to amplify and express the purified recombinant enzyme.
5. Purification of recombinant enzymes
(1) Lysing the cells with an appropriate amount of PBS (pH 7.5), 10% glycerol and 1mmol/L phenylmethylsulfonyl fluoride (Phenylmethylsulfonyl fluoride, PMSF), mixing well, and lysing with an ultrasonic breaker for 20min; centrifuging at 12000r/min for 10min, separating supernatant (supernatant protein mixture to be purified), and retaining precipitate;
(2) Adding a certain amount of treated Ni resin into the supernatant mixed solution, placing the mixture in a shaking table at 4 ℃ for incubation for 30min, collecting the resin, and purifying according to the following steps:
(3) According to the purification result, the target protein is collected for dialysis, the concentration of the detected protein is 1100 mug/mL, the SDS-PAGE detection result is shown in figure 3, and the molecular weight of the recombinant expressed multi-copper oxidase is about 55 kDa.
EXAMPLE 3 investigation of the enzymatic Properties of recombinant multiple copper oxidases
The effect of different concentrations of recombinase on degrading AFB 1 was verified, while the effects of different incubation temperatures, different pH, enzyme kinetic parameters and different metal ions were determined.
(1) Preparation of different concentrations of recombinase: the purified recombinase (1100. Mu.g/mL) was diluted with PBS to 5.00. Mu.g/mL, 2.50. Mu.g/mL, 1.00. Mu.g/mL, 0.75. Mu.g/mL, 0.50. Mu.g/mL, 0.25. Mu.g/mL, 0.10. Mu.g/mL, 0.05. Mu.g/mL, 0.025. Mu.g/mL, and the mixture was reacted in the absence of light at 37℃for 24 hours using PBS as a control group to determine the degradation rate of AFB 1.
(2) Treatment at different incubation temperatures: AFB 1 was added to the diluted recombinase to a final concentration of 1. Mu.g/mL, and the mixture was incubated at 28℃at 37℃at 40℃at 50℃at 60℃at 70℃at 80℃at 90℃at 100℃respectively, and the mixture was reacted in the absence of light for 24 hours with PBS as a control group to measure the degradation rate of AFB 1.
(3) Treatment at different pH: and respectively regulating the pH value of the recombinase to 2, 3, 4, 5, 6, 7 and 8 by using citrate buffer solution and sodium hydrophosphate buffer solution, taking PBS as a control group, carrying out light-shielding reaction for 24 hours at 37 ℃, and measuring the degradation rate of the AFB 1.
(4) Determination of enzyme kinetics Km and Vmax values: the recombinase Km and Vmax values were determined by double reciprocal mapping. The equation is as follows:
[ S ] is the substrate concentration, which is 0.20. Mu.g/mL, 0.50. Mu.g/mL, 1.00. Mu.g/mL, 1.50. Mu.g/mL, 2.50. Mu.g/mL. mu.L of recombinase (0.05. Mu.g/mL) and 100. Mu.L of AFB 1 at different concentrations were added and incubated at 37℃for 1h. After the completion of the culture, the degradation rate of AFB 1 was measured.
Definition: reaction rate = AFB 1 degradation/(reaction volume x reaction time). In this test, the reaction rate=afb 1 degradation/(1 ml×1 h), km, vmax were calculated.
(5) Different metal ion treatments: FeSO4、ZnSO4、CuSO4、FeCl3、CaCl2、NiCl2、MgCl2、MnSO4 serving as the sole metal ion additive is added into a degradation reaction system to enable the final concentration to be 10mmol/L, 0.05 mug/mL recombinase which is free of metal ions and sterile PBS and has the same final concentration of AFB 1 is used as a control, and the degradation rate of AFB 1 is measured by carrying out light-proof reaction for 24 hours at 37 ℃.
As can be seen from FIG. 4, the degradation rate of AFB 1 by the recombinase was significantly lower (P < 0.05) than that of the other 7 groups (enzyme concentration of 5.00. Mu.g/mL, 1.00. Mu.g/mL, 0.75. Mu.g/mL, 0.50. Mu.g/mL, 0.10. Mu.g/mL, 0.05. Mu.g/mL or 0.025. Mu.g/mL) at recombinase concentrations of 0.25. Mu.g/mL and 2.50. Mu.g/mL. Considering the practical application cost of the recombinase, the subsequent experiments all adopt the recombinase with the concentration of 0.05 mug/mL to co-culture with AFB 1 for subsequent researches.
As can be seen from fig. 5, the rate of degradation of AFB 1 by the recombinase at pH 7 and 8 was significantly higher (P < 0.05) than that of the other 5 groups (pH 2,3,4, 5 or 6).
As can be seen from FIG. 6, the degradation rate of AFB 1 by the recombinase was significantly lower (P < 0.05) than that of the other 3 groups (incubation temperature 37 ℃, 40 ℃ or 50 ℃) at 60 ℃ and 70 ℃.
As can be seen from fig. 7, the double reciprocal method is used to plot, the linear equation is y=1.165x+1.3343, and r 2 is 0.9929. As a result of calculation, the Km value of the Michaelis constant of the recombinase to AFB 1 was 0.87. Mu.g/mL, and the maximum reaction rate Vmax was 0.75. Mu.g/(mL. Times.h).
As can be seen from fig. 8, the addition of Fe 2+、Ni2+、Mn2+ and Zn 2+ significantly (P < 0.05) inhibited the effect of the recombinase on degradation of AFB 1 compared to the control group (the recombinase group without added metal ions).
Claims (10)
1. A recombinant enzyme has an amino acid sequence shown in SEQ ID NO. 1.
2. A gene encoding the recombinase of claim 1, wherein the nucleotide sequence is shown in SEQ ID NO. 2.
3. An expression vector comprising the gene of claim 2.
4. A recombinant bacterium comprising the recombinase of claim 1.
5. A method for preparing the recombinase of claim 1, comprising the steps of:
(1) The gene sequence of the recombinant enzyme is connected with a vector plasmid in an enzyme digestion way, so as to obtain an expression vector containing a target gene;
(2) Transforming competent cells by using the obtained expression vector to obtain recombinant bacteria for expressing the target protein;
(3) And separating and purifying the recombinant enzyme from the recombinant bacteria.
6. The method for producing a recombinase according to claim 5, wherein: the competent cells were E.coli T7E cells.
7. The use of the recombinase of claim 1, or a coding gene thereof, or an expression vector thereof or recombinant bacteria for degrading aflatoxin B 1.
8. A method for degrading aflatoxin B 1, which is characterized by comprising the following steps: the recombinant enzyme of claim 1 is added to a contaminated sample of aflatoxin B 1 for enzymatic reactions.
9. The method for degrading aflatoxin B 1 according to claim 8, wherein: the temperature of the enzymatic reaction is 30-50 ℃, and the pH value is neutral or alkalescent.
10. An enzyme preparation for degrading aflatoxin B 1 comprising the recombinase of claim 1.
Publications (1)
Publication Number | Publication Date |
---|---|
CN118256459A true CN118256459A (en) | 2024-06-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100850640B1 (en) | A detoxifizyme having activity of transforming aflatoxin and the gene encodes thereof | |
US11634694B2 (en) | Manganese peroxidase, gene thereof, and use thereof in detoxification of mycotoxin | |
Xu et al. | Genome mining reveals the genes of carboxypeptidase for OTA-detoxification in Bacillus subtilis CW14 | |
Liu et al. | Fusion expression of pedA gene to obtain biologically active pediocin PA-1 in Escherichia coli | |
CN113528477A (en) | Aflatoxin B capable of degrading1Construction method and application of manganese peroxidase mutant | |
CN114277004B (en) | High-temperature-resistant recombinant mutant SOD and encoding gene and application thereof | |
CN113046337B (en) | Pantolactone hydrolase mutant strain and application thereof | |
CN112301010B (en) | Amine oxidase ACAO, preparation method and application | |
CN106519023A (en) | Gene cloning method, expressing method and application of psychrophilic yeast metallothionein | |
CN111944790B (en) | Neutral protease gene, neutral protease, preparation method and application thereof | |
CN118256459A (en) | Recombinase and application thereof in degradation of aflatoxin B1Application in (a) | |
CN104694514B (en) | A kind of dehalogenase DhmB and its encoding gene and application | |
CN113999826B (en) | Bacterial laccase allosteric and preparation method thereof | |
CN105754969A (en) | Beta-galactosidase mutant and related biological material and application thereof | |
JP2011103863A (en) | Gene encoding protein having deoxynivalenol decomposing activity | |
JP2011103864A (en) | Gene encoding protein having deoxynivalenol and nivalenol decomposing activity | |
CN110066814B (en) | beta-D-glucosidase gene and encoding protein thereof | |
Gibson et al. | Biotechnology and Genetic Engineering | |
CN116426547B (en) | Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof | |
CN109907210B (en) | acyl-CoA thioesterase, application of gene thereof in degradation of zearalenone and preparation for degradation of zearalenone | |
Ai et al. | Secreting recombinant barnase by Lactococcus lactis and its application in reducing RNA from forages | |
CN105154413A (en) | Thermophilic lactase | |
CN116790532A (en) | Iron redox protein reductase mutant, recombinant bacterium thereof and application thereof | |
CN115717131A (en) | Recombinant tyrosinase mutant and application thereof | |
CN117737044A (en) | Neutral protease with high activity and tolerance, and encoding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication |